N/A N=44 Randomized Single-blind Prevention

Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics

Sarcopenia

Bottom Line

View on ClinicalTrials.gov: NCT04830514 ↗

Enrolled (actual)

Serious AEs

2.3%

Results posted

Aug 2023

Primary outcome: Primary: Whole Body Protein Turnover — -0.16; -0.17; 0.48 g/kg lean body mass/day

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Recommended Dietary Allowance of Protein (Other); Habitual protein intake (Other); Optimal Protein Intake (Other)
Age: Adult, Older Adult · 50+ yrs
Sex: All
Sponsor: University of Arkansas
Primary completion: Mar 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Whole Body Protein Turnover	-0.16; -0.17; 0.48	—

Summary

A randomized study to demonstrate how animal-based protein-rich food sources can be used by older adults to increase protein intake within pre-existing dietary patterns.

Eligibility Criteria

Inclusion Criteria

BMI ≤ 35 kg/m2
Capable of providing informed consent
COVID-19 negative and/or asymptomatic

Exclusion Criteria

Subject who does not/will not eat animal protein sources.
Body mass index > 35.
History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment.
Use of insulin to control blood sugar level.
Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy.
Currently using prescription blood thinning medications.
Unable or unwilling to suspend aspirin use for 7 days prior to Visit 3.
Unwilling to avoid using protein or amino-acid supplements during participation.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04830514). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.